ISSN:
2181-3906
2025
International scientific journal
«MODERN SCIENCE АND RESEARCH»
VOLUME 4 / ISSUE 8 / UIF:8.2 / MODERNSCIENCE.UZ
55
MORPHOLOGICAL CHANGES AT THE HEPATOCYTE LEVEL IN PATIENTS
WITH CHRONIC HEPATITIS B AND C
Raxmonov Komiljon Shuhratovich
2nd-year student, Asia international university, Bukhara, Uzbekistan.
komiljonraxmonov.uz@gmail.com
https://doi.org/10.5281/zenodo.16756927
Abstract.
Chronic hepatitis B and C infections remain among the most pressing global
public health challenges due to their widespread prevalence, silent progression, and potential to
cause irreversible liver damage. The hepatotropic nature of HBV and HCV leads to persistent
inflammation, immune-mediated injury, and significant morphological alterations at the
hepatocyte level, ultimately resulting in fibrosis, cirrhosis, and hepatocellular carcinoma. This
study aims to comprehensively evaluate and characterize the cellular and subcellular
morphological changes in hepatocytes in patients with chronic viral hepatitis B and C. Emphasis
is placed on cytoplasmic vacuolization, nuclear polymorphism, ballooning degeneration,
apoptotic and necrotic changes, Mallory-Denk bodies, and mitochondrial dysfunction. By
integrating histopathological findings with current virological and immunological data, the
study highlights the mechanisms by which chronic infection alters liver architecture and
function. The analysis also underscores the role of liver biopsy and advanced imaging
techniques in detecting these morphological patterns and supports the development of targeted
therapeutic strategies. These insights are critical for improving early diagnosis, patient
stratification, and long-term clinical outcomes in individuals affected by chronic viral hepatitis.
Keywords
: Chronic hepatitis B, chronic hepatitis C, hepatocyte injury, morphological
changes, histopathology, liver biopsy, viral hepatitis, ballooning degeneration, Mallory-Denk
bodies, hepatic fibrosis, hepatocellular carcinoma.
Chronic viral hepatitis, particularly infections caused by hepatitis B virus (HBV) and
hepatitis C virus (HCV), represents a major public health concern globally due to its high
prevalence, long-term asymptomatic progression, and significant risk of severe complications
such as liver cirrhosis and hepatocellular carcinoma (HCC). As reported by the World Health
Organization (WHO), an estimated 296 million individuals were living with chronic HBV and
approximately 58 million with chronic HCV worldwide as of 2022, with over 1.1 million deaths
annually attributed to related liver diseases. Despite advances in vaccination programs for HBV
and the availability of direct-acting antiviral agents (DAAs) for HCV, the global burden remains
significant, especially in regions with limited access to diagnostic tools and treatment. The liver,
being a vital metabolic and detoxifying organ, is particularly susceptible to viral aggression, with
hepatocytes as the primary targets of infection and immune-mediated injury. Chronic infection
with HBV or HCV initiates a cascade of pathogenic processes including persistent inflammation,
oxidative stress, mitochondrial dysfunction, and immunological disturbances, all of which
culminate in structural and functional alterations of hepatocytes. These morphological changes—
ranging from cellular ballooning and hydropic degeneration to the formation of Mallory-Denk
bodies, apoptotic bodies, and nuclear polymorphism—are crucial histopathological hallmarks of
ongoing liver injury.
ISSN:
2181-3906
2025
International scientific journal
«MODERN SCIENCE АND RESEARCH»
VOLUME 4 / ISSUE 8 / UIF:8.2 / MODERNSCIENCE.UZ
56
They provide essential insights into disease severity, stage, and progression and serve as a
basis for therapeutic decision-making. A comprehensive evaluation of these cellular alterations,
combined with virological and immunohistochemical profiling, offers a deeper understanding of
the mechanisms underlying chronic viral hepatitis and informs clinical strategies aimed at early
detection, risk stratification, and personalized treatment. The objective of this study is to
systematically examine the morphological manifestations of hepatocyte injury in chronic HBV
and HCV infections and to elucidate their clinical and prognostic significance within the broader
context of liver pathology.
Pathophysiology of hepatocyte injury in chronic HBV and HCV infections
The pathophysiological mechanisms underlying hepatocyte injury in chronic hepatitis B
and C infections are complex and multifactorial, involving direct viral effects, host immune
responses, and chronic inflammation-driven cellular stress. Hepatitis B virus (HBV), a partially
double-stranded DNA virus, and hepatitis C virus (HCV), a single-stranded RNA virus, differ in
their replication strategies and interaction with the host immune system; however, both
ultimately lead to chronic liver damage through sustained immune-mediated cytotoxicity and
hepatocellular degeneration. Upon infection, HBV does not exert direct cytopathic effects in
most cases; instead, liver damage is largely a consequence of cytotoxic T lymphocyte (CTL)-
mediated lysis of infected hepatocytes as part of the host's antiviral immune defense. HCV, on
the other hand, has more direct cytopathic properties and can also provoke endoplasmic
reticulum (ER) stress, oxidative stress, and mitochondrial dysfunction within hepatocytes, all of
which contribute to cellular injury and death. The chronic inflammatory environment sustained
by both viruses results in increased production of pro-inflammatory cytokines such as TNF-α,
IL-6, and IFN-γ, as well as reactive oxygen species (ROS), which impair the hepatocyte’s
antioxidant defense systems and damage macromolecules including lipids, proteins, and DNA.
These molecular events cause morphological changes at the cellular level such as ballooning
degeneration, cytoplasmic rarefaction, nuclear pleomorphism, steatosis, and apoptotic div
formation. In particular, HCV infection is strongly associated with hepatic steatosis due to its
interference with lipid metabolism pathways. Continuous injury and regeneration cycles lead to
aberrant hepatocyte proliferation, fibrogenesis, and ultimately architectural distortion of the liver
parenchyma. Histopathologically, chronic hepatitis is graded based on the degree of
necroinflammatory activity and staged according to the extent of fibrosis using scoring systems
like METAVIR or Ishak. Furthermore, chronic injury induces activation of hepatic stellate cells
(HSCs), which contribute to extracellular matrix deposition and scar tissue formation. Over time,
these mechanisms not only compromise liver function but also set the stage for cirrhosis and the
potential development of hepatocellular carcinoma. Understanding the intricate cellular and
molecular processes driving hepatocyte injury in chronic HBV and HCV infections is critical for
developing effective diagnostic markers and therapeutic interventions aimed at halting or
reversing liver damage.
Morphological changes of hepatocytes in chronic hepatitis B and C
The morphological alterations of hepatocytes in chronic hepatitis B and C infections
reflect the underlying pathological processes driven by persistent viral replication, immune-
mediated cytotoxicity, and oxidative stress.
ISSN:
2181-3906
2025
International scientific journal
«MODERN SCIENCE АND RESEARCH»
VOLUME 4 / ISSUE 8 / UIF:8.2 / MODERNSCIENCE.UZ
57
These changes, which can be observed using light and electron microscopy, are crucial
indicators of liver injury and disease progression. In chronic hepatitis B (CHB), hepatocytes
frequently exhibit ground-glass appearance, which is due to the accumulation of hepatitis B
surface antigen (HBsAg) within the endoplasmic reticulum. This is often accompanied by
cytoplasmic swelling, increased eosinophilia, and fine granular cytoplasmic inclusions.
Ballooning degeneration, characterized by swollen hepatocytes with rarefied cytoplasm
and indistinct cell borders, is another common feature, especially in advanced inflammatory
stages. Inflammatory infiltrates, predominantly composed of lymphocytes and plasma cells,
surround the portal tracts and interface zones, contributing to piecemeal necrosis and apoptotic
cell death. In chronic hepatitis C (CHC), hepatocytes display a broader range of morphological
abnormalities. Steatosis, or fatty change, is a hallmark feature and is present in up to 50% of
patients, particularly those with HCV genotype 3. The accumulation of lipid droplets within the
cytoplasm results from viral-induced disruption of lipid metabolism and mitochondrial
dysfunction. Other notable features include cytoplasmic vacuolization, acidophilic bodies
(apoptotic hepatocytes), and the presence of Mallory-Denk bodies, which are aggregates of
misfolded cytoskeletal proteins. Nuclear changes such as irregular nuclear contours,
binucleation, and chromatin margination also reflect hepatocyte stress and regenerative activity.
Both CHB and CHC are associated with varying degrees of necrosis, apoptosis, and
regeneration, leading to architectural disruption over time. The presence of mitotic figures,
anisocytosis, and increased nuclear-cytoplasmic ratio may indicate regenerative hyperplasia or,
in some cases, pre-neoplastic transformation. The chronicity of these infections perpetuates the
cycle of injury and repair, which contributes to fibrogenesis and the eventual development of
cirrhosis. Staging of liver disease using histopathological scoring systems enables correlation of
these morphological findings with clinical outcomes and informs decisions regarding treatment
urgency and surveillance strategies. The integration of histological examination with clinical and
virological parameters enhances the understanding of disease behavior and response to antiviral
therapy.
Diagnostic and histopathological assessment of hepatocyte injury
Accurate diagnosis and evaluation of hepatocyte injury in chronic viral hepatitis require a
multidisciplinary approach that integrates clinical, biochemical, virological, imaging, and
histopathological data to determine disease severity, progression, and therapeutic strategy. Serum
biomarkers such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), bilirubin
levels, and viral load quantification (HBV DNA or HCV RNA) provide preliminary information
about liver inflammation and viral activity but are insufficient to capture the full extent of
cellular and structural damage. Imaging modalities such as ultrasound, transient elastography
(FibroScan), and magnetic resonance elastography are useful non-invasive tools to assess liver
stiffness and fibrosis, though they cannot directly visualize hepatocyte morphology.
Histopathological examination of liver biopsy remains the gold standard for assessing the degree
of hepatocellular damage, necroinflammation, steatosis, and fibrosis. Under light microscopy
with hematoxylin and eosin staining, hepatocyte injuries are revealed as ballooning degeneration,
acidophilic (Councilman) bodies, cytoplasmic inclusions, ground-glass appearance, and nuclear
pleomorphism, each representing different stages and mechanisms of cellular insult.
ISSN:
2181-3906
2025
International scientific journal
«MODERN SCIENCE АND RESEARCH»
VOLUME 4 / ISSUE 8 / UIF:8.2 / MODERNSCIENCE.UZ
58
Special stains such as Masson's trichrome or Sirius Red help evaluate the extent of
fibrosis, while periodic acid–Schiff (PAS) and reticulin staining assist in detecting structural
alterations in the hepatocellular framework. Immunohistochemical techniques enhance
diagnostic precision by detecting viral antigens (e.g., HBsAg, HBcAg) or apoptotic markers
(e.g., caspase-3), providing insight into the localization and activity of viral replication and
immune-mediated apoptosis. Furthermore, electron microscopy enables visualization of
subcellular changes including mitochondrial swelling, dilated rough endoplasmic reticulum, and
disruption of desmosomal junctions, offering a deeper understanding of the ultrastructural
damage occurring within infected hepatocytes. Standardized scoring systems such as the
METAVIR, Ishak, and Knodell indices allow quantification of necroinflammatory activity and
fibrosis stage, which are crucial for predicting prognosis and determining eligibility for antiviral
treatment or liver transplantation. Advances in digital pathology and artificial intelligence-driven
histological analysis are further refining diagnostic accuracy and enabling more objective
assessment of hepatocellular injury patterns. Therefore, comprehensive diagnostic and
histological evaluation not only informs individualized treatment planning but also enhances our
understanding of the pathogenesis and progression of chronic HBV and HCV infections.
Therapeutic implications and prognostic significance of hepatocyte damage in
chronic viral hepatitis
The extent and nature of hepatocyte injury in chronic viral hepatitis have direct
therapeutic implications and serve as critical indicators of disease prognosis. In patients with
chronic HBV or HCV infection, the degree of hepatocyte degeneration, necroinflammatory
activity, and fibrosis progression fundamentally influence clinical decision-making, including the
timing of antiviral therapy initiation, treatment modality, and monitoring strategies. For HBV,
the presence of significant hepatocellular damage, as evidenced by elevated ALT levels and
histological activity, necessitates the use of potent nucleos(t)ide analogues such as tenofovir or
entecavir, which effectively suppress viral replication and mitigate further hepatocyte
destruction. In the case of HCV, direct-acting antiviral agents (DAAs) offer high cure rates
regardless of fibrosis stage; however, patients with advanced hepatocyte damage and cirrhosis
may require extended treatment duration and careful post-treatment surveillance.
Histopathological findings of ballooning, apoptosis, and Mallory-Denk bodies often
indicate ongoing oxidative stress and endoplasmic reticulum dysfunction, which correlate with
poor therapeutic response and elevated risk of hepatocellular carcinoma (HCC). Moreover, the
identification of ground-glass hepatocytes in HBV or steatosis in HCV patients may suggest
specific viral genotypes or coexisting metabolic liver disease, necessitating a personalized
treatment approach. The degree of hepatocyte damage is also a key determinant of liver
regeneration capacity and informs eligibility for liver transplantation in end-stage disease.
Prognostically, the presence of extensive hepatocyte apoptosis, bridging necrosis, and
regenerative nodules correlates with faster fibrosis progression, reduced response to antiviral
therapy, and higher incidence of cirrhosis and HCC. Regular monitoring using non-invasive
biomarkers, imaging, and, when needed, follow-up biopsy is essential to assess treatment
efficacy and adjust therapy. Future directions in the management of chronic hepatitis will likely
focus on targeting intracellular pathways responsible for hepatocyte injury, such as
ISSN:
2181-3906
2025
International scientific journal
«MODERN SCIENCE АND RESEARCH»
VOLUME 4 / ISSUE 8 / UIF:8.2 / MODERNSCIENCE.UZ
59
mitochondrial protection, oxidative stress modulation, and immune checkpoint regulation. Thus,
comprehensive understanding of hepatocyte damage is not only pivotal for guiding current
therapeutic strategies but also for developing novel interventions aimed at preserving liver
architecture and function, ultimately improving long-term clinical outcomes in chronic viral
hepatitis.
Conclusion
: Chronic viral hepatitis caused by HBV and HCV remains a global public
health burden due to its progressive hepatocellular injury, leading to fibrosis, cirrhosis, and
hepatocellular carcinoma. The detailed understanding of hepatocyte damage mechanisms—
ranging from viral cytopathic effects and immune-mediated apoptosis to oxidative stress-induced
degeneration—forms the cornerstone for accurate diagnosis, risk stratification, and personalized
treatment strategies. Diagnostic approaches that integrate histopathological assessment with non-
invasive markers offer critical insights into the extent of liver damage and facilitate timely
therapeutic interventions. The histological identification of specific injury patterns such as
ballooning, necrosis, and steatosis not only reflects disease activity but also predicts response to
antiviral therapy and long-term outcomes. As antiviral regimens evolve and curative therapies
become more accessible, the recognition of histological and molecular determinants of
hepatocyte injury gains even greater significance in optimizing care. Furthermore, the prognostic
implications of hepatocellular damage necessitate lifelong monitoring and proactive management
to prevent irreversible liver failure and malignancy. Advancements in digital pathology,
molecular diagnostics, and targeted therapies promise to further refine our ability to detect, treat,
and reverse hepatocyte damage in chronic viral hepatitis. Therefore, a comprehensive,
multidisciplinary understanding of hepatocyte injury not only enhances clinical practice today
but also paves the way for innovation in the prevention and management of liver disease
globally.
References
1.
Толибов, Ф. (2024). ИММУННАЯ СИСТЕМА: АНАТОМИЯ ЛИМФАТИЧЕСКОЙ
СИСТЕМЫ И МЕХАНИЗМЫ ИММУННОГО ОТВЕТА. Журнал академических
исследований нового Узбекистана, 1(2), 55-58.
2.
Farxodivich, T. F. (2024).
The Syndrome of External Secretory Function Insufficiency is a
Common Complication of Chronic Pancreatitis
.American Journal of Bioscience and
Clinical Integrity 1 (10), 90-95
3.
Farxodivich, T. F. (2024). Clinical Characteristics of Gastritis in Digestive Diseases.
Research Journal of Trauma and Disability Studies, 3(3), 294-299.
4.
Farxodivich, T. F. (2024). INFECTION OF COVID-19 ON COGNITIVE FUNCTIONS.
SCIENTIFIC JOURNAL OF APPLIED AND MEDICAL SCIENCES, 3(4), 325-330.
5.
Tolibov F.F. -
VIOLATION OF PLATELET AGGREGATION AND IMBALANCE OF
HEMOSTASIS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS C//New Day in
Medicine 6(68)2024 264-268
https://newdayworldmedicine.com/en/article/3758
6.
Tolibov F.F.-
CLINICAL AND MORPHOLOGICAL CORRELATIONS OF LIVER
.European Journal of Modern Medicine and Practice 4 (11), 515-520
ISSN:
2181-3906
2025
International scientific journal
«MODERN SCIENCE АND RESEARCH»
VOLUME 4 / ISSUE 8 / UIF:8.2 / MODERNSCIENCE.UZ
60
7.
TF Farhodivich.
CHOLESTASIS IS A RISK FACTOR FOR THE DEVELOPMENT OF
.Научный Фокус 2 (21), 317-321
8.
Tolibov F.F
IMPACT OF CORTICOSTEROID AND IMMUNOSUPPRESSIVE
THERAPY ON THE COURSE OF CHRONIC HEPATITIS: RISKS AND
PROSPECTS
.Modern Science and Research 4 (2), 1123-1132
9.
RK Shuhrat o’g’li, TF Farhodivich.
.JOURNAL OF INNOVATIONS IN SCIENTIFIC AND
EDUCATIONAL RESEARCH 8 (1), 195-202
10.
F Tolibov.
PATHOMORPHOLOGICAL ABNORMALITIES OF THE LIVER IN
PATIENTS INFECTED WITH THE HEPATITIS B VIRUS
.Modern Science and
Research 4 (3), 1084-1093
11.
F Tolibov.
MONONUCLEAR CELL INFILTRATION ACCOMPANIED BY THE
PROGRESSION OF FIBROTIC AND CIRRHOTIC TRANSFORMATIONS IN THE
LIVER TISSUE
.Modern Science and Research 4 (4), 926-936
12.
10. Raxmonov KSh, Tolibov FF PORTAL - GIPERTENZIYA FONIDA GEPATIK
ENSEFALOPATIYA RIVOJLANISHINING KLINIK XUSUSIYATLARI: Vol. 21 No
1(2025): Yangi O’zbekiston tarqaqqiyotida tadqiqotlarni o’rni va rivojlanish omillari
